Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2019

Open Access 01-02-2019 | Research Article

The impact of a pharmacist on post-take ward round prescribing and medication appropriateness

Authors: B. Bullock, P. Donovan, C. Mitchell, J. A. Whitty, I. Coombes

Published in: International Journal of Clinical Pharmacy | Issue 1/2019

Login to get access

Abstract

Background Medication communication and prescribing on the post-take ward round following patient admission to hospital can be suboptimal leading to worse patient outcomes. Objective To evaluate the impact of clinical pharmacist participation on the post-take ward round on the appropriateness of medication prescribing, medication communication, and overall patient health care outcomes. Setting Tertiary referral teaching hospital, Brisbane, Australia. Method A pre-post intervention study was undertaken that compared the addition of a senior clinical pharmacist attending the post-take ward was compared to usual wardbase pharmacist service, with no pharmacist present of the post-take ward round. We assessed the proportion of patients with an improvement in medication appropriateness from admission to discharge, using the START/STOPP checklists. Medication communication was assessed by the mean number of brief and in-depth discussions, with health care outcomes measured by comparing length of stay and 28-day readmission rates. Main outcome measures: Medication appropriateness according to the START/STOPP list, number and type of discussions with team members and length of stay and readmission rate. Results Two hundred and sixty patients were recruited (130 pre- and 130-post-intervention), across 23 and 20 post-take ward rounds, respectively. Post-intervention, there was increase in the proportion of patients who had an improvement medication appropriateness (pre-intervention 25.4%, post-intervention 36.9%; p = 0.004), the number of in-depth discussions about patients’ medication (1.9 ± 1.7 per patient pre-intervention, 2.7 ± 1.7 per patient post-, p < 0.001), and the number relating to high-risk medications (0.71 ± 1.1 per patient pre-intervention, to 1.2 ± 1.2 per patient post-, p < 0.05). Length of stay and 28-day mortality were unchanged. Conclusion Clinical pharmacist participation on the post-take ward round leads to improved medication-related communication and improved medication appropriateness but did not significantly improve health care outcomes.
Literature
1.
go back to reference Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15:i49–59.CrossRefPubMed Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15:i49–59.CrossRefPubMed
3.
go back to reference Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. J Am Med Assoc. 1999;282(3):267–70.CrossRef Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. J Am Med Assoc. 1999;282(3):267–70.CrossRef
4.
go back to reference Scarsi K, Fotis M, Noskin G. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm. 2002;59:2089–92.CrossRefPubMed Scarsi K, Fotis M, Noskin G. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm. 2002;59:2089–92.CrossRefPubMed
5.
go back to reference Kwan JL, Lo L, Sampson M, Shojania KG. Medication reconciliation during transitions of care as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5):397–403.CrossRefPubMed Kwan JL, Lo L, Sampson M, Shojania KG. Medication reconciliation during transitions of care as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5):397–403.CrossRefPubMed
6.
go back to reference Society of Hospital Pharmacists of Australia. SHPA Standards of practice for clinical pharmacy services. J Pharm Pract Res. 2013;43(2):122–46.CrossRef Society of Hospital Pharmacists of Australia. SHPA Standards of practice for clinical pharmacy services. J Pharm Pract Res. 2013;43(2):122–46.CrossRef
7.
go back to reference Kaboli PJ, Hoth AB, McClimon MD, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.CrossRefPubMed Kaboli PJ, Hoth AB, McClimon MD, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.CrossRefPubMed
8.
go back to reference Walton V, Hodgen A, Johnson J, Greenfield D. Ward rounds, participants, roles and perceptions: literature review. Int J Health Care Qual Assur. 2016;29(4):364–79.CrossRefPubMed Walton V, Hodgen A, Johnson J, Greenfield D. Ward rounds, participants, roles and perceptions: literature review. Int J Health Care Qual Assur. 2016;29(4):364–79.CrossRefPubMed
9.
go back to reference Myers B, Mitchell C, Whitty J, Donovan P, Coombes I. Prescribing and medication communication on the post-take ward round. Intern Med J. 2017;47(4):454–7.CrossRefPubMed Myers B, Mitchell C, Whitty J, Donovan P, Coombes I. Prescribing and medication communication on the post-take ward round. Intern Med J. 2017;47(4):454–7.CrossRefPubMed
10.
go back to reference Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.CrossRefPubMed Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.CrossRefPubMed
11.
go back to reference Makowsky MJ, Koshman SL, Midodzi WK, Tsuyuki RT. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATIVE study. Med Care. 2009;47(6):642–50.CrossRefPubMed Makowsky MJ, Koshman SL, Midodzi WK, Tsuyuki RT. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATIVE study. Med Care. 2009;47(6):642–50.CrossRefPubMed
12.
go back to reference Lo E, Rainkie D, Semchuk W, Gorman S, Toombs K, Slavik R, et al. Measurement of clinical pharmacy key performance indicators to focus and improve your hospital pharmacy practice. Innov Clin Pharm Pract Clin Pract. 2016;69(2):149–55. Lo E, Rainkie D, Semchuk W, Gorman S, Toombs K, Slavik R, et al. Measurement of clinical pharmacy key performance indicators to focus and improve your hospital pharmacy practice. Innov Clin Pharm Pract Clin Pract. 2016;69(2):149–55.
13.
go back to reference Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014–8.CrossRefPubMed Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014–8.CrossRefPubMed
14.
go back to reference Australian Council for Safety and Quality in Health Care. Second national report on patient safety. Canberra; 2002. Australian Council for Safety and Quality in Health Care. Second national report on patient safety. Canberra; 2002.
15.
go back to reference Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening tool of older person’s prescriptions) and START (Screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.CrossRefPubMed Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening tool of older person’s prescriptions) and START (Screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.CrossRefPubMed
16.
go back to reference Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–72. https://doi.org/10.1111/jcpt.12059.CrossRefPubMed Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–72. https://​doi.​org/​10.​1111/​jcpt.​12059.CrossRefPubMed
17.
go back to reference O’Mahony D, O’Sullivan D, Byrne S, O’Connell MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMed O’Mahony D, O’Sullivan D, Byrne S, O’Connell MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMed
19.
go back to reference Herring R, Desai T, Caldwell G. Quality and safety at the point of care: how long should a ward round take? Clin Med (Lond). 2011;11(1):20–2.CrossRef Herring R, Desai T, Caldwell G. Quality and safety at the point of care: how long should a ward round take? Clin Med (Lond). 2011;11(1):20–2.CrossRef
Metadata
Title
The impact of a pharmacist on post-take ward round prescribing and medication appropriateness
Authors
B. Bullock
P. Donovan
C. Mitchell
J. A. Whitty
I. Coombes
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0775-9

Other articles of this Issue 1/2019

International Journal of Clinical Pharmacy 1/2019 Go to the issue